Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Teitel

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 8, 2017
The authors respond to "Is referral necessary for abnormal bleeding?"Michelle Sholzberg, Jerome Teitel, Lisa K Hicks
Blood|November 22, 2007
Induction of an inhibitor antibody to factor XI in a patient with severe inherited factor XI deficiency by Rh immune globulinMichal Zucker, Ariella Zivelin, Jerome Teitel, et al.
Blood Reviews|May 20, 2008
From theory to practice: applying current clinical knowledge and treatment strategies to the care of hemophilia a patients with inhibitorsEdward D Gomperts, Jan Astermark, Alessandro Gringeri, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 26, 2014
Evaluation of algorithms for the treatment of problem bleeding episodes in patients with hemophilia having inhibitorsGuy Young, Jerome Teitel, Roseline d'Oiron, et al.
Journal of Blood Medicine|December 1, 2021
Final Results of the Prospective ADVATE<sup>®</sup> Immune Tolerance Induction Registry (PAIR) Study with Plasma- and Albumin-Free Recombinant Factor VIIIAmy D Shapiro, Alejandro Fernandez, Jerome Teitel, et al.
Rambam Maimonides Medical Journal|December 30, 2024
Antisemitism in Medicine: An International PerspectiveMichael Gordon, Jerome Teitel, Ted Rosenberg, et al.
Journal of Thrombosis and Thrombolysis|December 22, 2022
Perioperative continuous infusions of factor VIII versus factor IX for patients with hemophilia A or B undergoing major surgeryBrandon Tse, Rosane Nisenbaum, Georgina Floros, et al.
Ejhaem|September 2, 2022
Lymphoma-associated acquired von Willebrand syndrome responsive to splenectomy: A case reportFatima Khadadah, Natasha Rupani, Jordan Scott, et al.
Research and Practice in Thrombosis and Haemostasis|December 14, 2020
Fibrinogen concentrate for bleeding in patients with congenital fibrinogen deficiency: Observational study of efficacy and safety for prophylaxis and treatmentJoseph Lasky, Jerome Teitel, Michael Wang, et al.
Research and Practice in Thrombosis and Haemostasis|September 1, 2020
Desmopressin responsiveness by age in type 1 von Willebrand diseaseNicola Goldberg, Rosane Nisenbaum, Hong Song, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 8, 2017
The authors respond to "Is referral necessary for abnormal bleeding?"Michelle Sholzberg, Jerome Teitel, Lisa K Hicks
Blood|November 22, 2007
Induction of an inhibitor antibody to factor XI in a patient with severe inherited factor XI deficiency by Rh immune globulinMichal Zucker, Ariella Zivelin, Jerome Teitel, et al.
Blood Reviews|May 20, 2008
From theory to practice: applying current clinical knowledge and treatment strategies to the care of hemophilia a patients with inhibitorsEdward D Gomperts, Jan Astermark, Alessandro Gringeri, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 26, 2014
Evaluation of algorithms for the treatment of problem bleeding episodes in patients with hemophilia having inhibitorsGuy Young, Jerome Teitel, Roseline d'Oiron, et al.
Journal of Blood Medicine|December 1, 2021
Final Results of the Prospective ADVATE<sup>®</sup> Immune Tolerance Induction Registry (PAIR) Study with Plasma- and Albumin-Free Recombinant Factor VIIIAmy D Shapiro, Alejandro Fernandez, Jerome Teitel, et al.
Rambam Maimonides Medical Journal|December 30, 2024
Antisemitism in Medicine: An International PerspectiveMichael Gordon, Jerome Teitel, Ted Rosenberg, et al.
Journal of Thrombosis and Thrombolysis|December 22, 2022
Perioperative continuous infusions of factor VIII versus factor IX for patients with hemophilia A or B undergoing major surgeryBrandon Tse, Rosane Nisenbaum, Georgina Floros, et al.
Ejhaem|September 2, 2022
Lymphoma-associated acquired von Willebrand syndrome responsive to splenectomy: A case reportFatima Khadadah, Natasha Rupani, Jordan Scott, et al.
Research and Practice in Thrombosis and Haemostasis|December 14, 2020
Fibrinogen concentrate for bleeding in patients with congenital fibrinogen deficiency: Observational study of efficacy and safety for prophylaxis and treatmentJoseph Lasky, Jerome Teitel, Michael Wang, et al.
Research and Practice in Thrombosis and Haemostasis|September 1, 2020
Desmopressin responsiveness by age in type 1 von Willebrand diseaseNicola Goldberg, Rosane Nisenbaum, Hong Song, et al.
Pageof 4